Globus Medical GMED
$ 84.56
1.14%
Quarterly report 2024-Q3
added 11-05-2024
Globus Medical Balance Sheet 2011-2024 | GMED
Annual Balance Sheet Globus Medical
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -195 M | -140 M | -119 M | -133 M | -60.2 M | -82.3 M | -90 M | -212 M | -143 M |
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
- | - | - | 1.34 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 18.2 M | 19 M | 17.7 M | 15.7 M | 36.1 M | 28.7 M | 26 M | 21.1 M | 17.6 M |
Total Current Liabilities |
159 M | 140 M | 121 M | 111 M | 96.1 M | 93.1 M | 79.9 M | 82.7 M | 89.4 M | 67.9 M | 39.5 M | 29.3 M |
Total Liabilities |
230 M | 216 M | 173 M | 130 M | 115 M | 111 M | 95.6 M | 119 M | 118 M | 93.9 M | 60.6 M | 46.9 M |
Deferred Revenue |
14.1 M | 12 M | 8.12 M | 5.4 M | 2.6 M | - | - | - | - | - | - | - |
Retained Earnings |
1.24 B | 1.19 B | 1.05 B | 1.05 B | 893 M | 736 M | 629 M | 525 M | 412 M | 319 M | 251 M | 177 M |
Total Assets |
2.08 B | 1.96 B | 1.68 B | 1.53 B | 1.3 B | 1.08 B | 928 M | 834 M | 704 M | 566 M | 447 M | 329 M |
Cash and Cash Equivalents |
150 M | 193 M | 239 M | 195 M | 140 M | 119 M | 133 M | 60.2 M | 82.3 M | 90 M | 212 M | 143 M |
Book Value |
1.85 B | 1.74 B | 1.51 B | 1.4 B | 1.19 B | 968 M | 832 M | 715 M | 585 M | 472 M | 387 M | 282 M |
Total Shareholders Equity |
1.85 B | 1.74 B | 1.51 B | 1.4 B | 1.19 B | 968 M | 832 M | 715 M | 585 M | 472 M | 387 M | 282 M |
All numbers in USD currency
Quarterly Balance Sheet Globus Medical
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
709 K | 684 K | 298 K | 669 K | - | - | - | - | - | - | 2.94 M | 3.3 M | 3.8 M | 3.45 M | 2.94 M | 2.94 M | 2.94 M | 2.94 M | 1.14 M | 871 K | 740 K | 803 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.02 B | 1.02 B | 1.02 B | 1.17 B | 227 M | 235 M | - | 212 M | - | 213 M | 216 M | 192 M | 191 M | 175 M | 173 M | 173 M | 173 M | 173 M | 130 M | 130 M | 130 M | 98.7 M | 115 M | 115 M | 115 M | 115 M | 111 M | 111 M | 111 M | 111 M | 95.6 M | 95.6 M | 95.6 M | 95.6 M | 119 M | 119 M | 119 M | 119 M | 118 M | 118 M | 118 M | 118 M | 93.9 M | 93.9 M | 93.9 M | 93.9 M | 60.6 M | 60.6 M | 60.6 M | 60.6 M | 46.9 M | 46.9 M | 46.9 M | - |
Deferred Revenue |
20.8 M | 19.8 M | 17.1 M | 18 M | 14.9 M | 13.5 M | - | 12.3 M | - | 11.8 M | 12 M | 9.67 M | 9 M | 8.65 M | 8.12 M | 8.12 M | 8.12 M | 8.12 M | 5.4 M | 5.4 M | 5.4 M | 2.79 M | 2.6 M | 2.6 M | 2.6 M | 2.6 M | 755 K | 755 K | 755 K | 755 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
1.13 B | 1.07 B | 1.05 B | 1.35 B | 1.35 B | 1.29 B | - | 1.19 B | - | 1.23 B | 1.19 B | 1.18 B | 1.13 B | 1.09 B | 1.05 B | 1.05 B | 1.05 B | 1.05 B | 1.05 B | 1.05 B | 1.05 B | 926 M | 893 M | 893 M | 893 M | 893 M | 736 M | 736 M | 736 M | 736 M | 629 M | 629 M | 629 M | 629 M | 525 M | 525 M | 525 M | 525 M | 412 M | 412 M | 412 M | 412 M | 319 M | 319 M | 319 M | 319 M | 251 M | 251 M | 251 M | 251 M | 177 M | 177 M | 177 M | - |
Total Assets |
5.09 B | 4.99 B | 4.94 B | 5.36 B | 2.21 B | 2.15 B | - | 1.98 B | - | 2 B | 1.96 B | 1.91 B | 1.83 B | 1.74 B | 1.68 B | 1.68 B | 1.68 B | 1.68 B | 1.53 B | 1.53 B | 1.53 B | 1.34 B | 1.3 B | 1.3 B | 1.3 B | 1.3 B | 1.08 B | 1.08 B | 1.08 B | 1.08 B | 928 M | 928 M | 928 M | 928 M | 834 M | 834 M | 834 M | 834 M | 704 M | 704 M | 704 M | 704 M | 566 M | 566 M | 566 M | 566 M | 447 M | 447 M | 447 M | 447 M | 329 M | 329 M | 329 M | - |
Cash and Cash Equivalents |
623 M | 410 M | 354 M | 280 M | 306 M | 218 M | - | 134 M | 151 M | 230 M | 193 M | 362 M | 269 M | 185 M | 239 M | 251 M | 166 M | 167 M | 195 M | 166 M | 195 M | 130 M | 140 M | 140 M | 140 M | 140 M | 119 M | 119 M | 119 M | 119 M | 67 M | 133 M | 133 M | 133 M | 57.7 M | 60.2 M | 60.2 M | 60.2 M | 82.3 M | 82.3 M | 82.3 M | 82.3 M | 90 M | 90 M | 90 M | 90 M | 212 M | 212 M | 212 M | 212 M | 143 M | 143 M | 143 M | - |
Book Value |
4.07 B | 3.98 B | 3.92 B | 4.19 B | 1.99 B | 1.91 B | - | 1.76 B | - | 1.79 B | 1.74 B | 1.72 B | 1.64 B | 1.56 B | 1.51 B | 1.51 B | 1.51 B | 1.51 B | 1.4 B | 1.4 B | 1.4 B | 1.24 B | 1.19 B | 1.19 B | 1.19 B | 1.19 B | 968 M | 968 M | 968 M | 968 M | 832 M | 832 M | 832 M | 832 M | 715 M | 715 M | 715 M | 715 M | 585 M | 585 M | 585 M | 585 M | 472 M | 472 M | 472 M | 472 M | 387 M | 387 M | 387 M | 387 M | 282 M | 282 M | 282 M | - |
Total Shareholders Equity |
4.07 B | 3.98 B | 3.92 B | 4.19 B | 1.99 B | 1.91 B | - | 1.76 B | 1.7 B | 1.79 B | 1.74 B | 1.72 B | 1.64 B | 1.56 B | 1.51 B | 1.51 B | 1.51 B | 1.51 B | 1.4 B | 1.4 B | 1.4 B | 1.24 B | 1.19 B | 1.19 B | 1.19 B | 1.19 B | 968 M | 968 M | 968 M | 968 M | 832 M | 832 M | 832 M | 832 M | 715 M | 715 M | 715 M | 715 M | 585 M | 585 M | 585 M | 585 M | 472 M | 472 M | 472 M | 472 M | 387 M | 387 M | 387 M | 387 M | 282 M | 282 M | 282 M | - |
All numbers in USD currency